|
1
|
Gargiulo P, Della Pepa C, Berardi S,
Califano D, Scala S, Buonaguro L, Ciliberto G, Brauchli P and
Pignata S: Tumor genotype and immune microenvironment in
POLE-ultramutated and MSI-hypermutated endometrial cancers: New
candidates for checkpoint blockade immunotherapy? Cancer Treat Rev.
48:61–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dudley JC, Lin MT, Le DT and Eshleman JR:
Microsatellite instability as a biomarker for PD-1 blockade. Clin
Cancer Res. 22:813–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bupathi M and Wu C: Biomarkers for immune
therapy in colorectal cancer: Mismatch-repair deficiency and
others. J Gastrointest Oncol. 7:713–720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Czink E, Kloor M, Goeppert B, Fröhling S,
Uhrig S, Weber TF, Meinel J, Sutter C, Weiss KH, Schirmacher P, et
al: Successful immune checkpoint blockade in a patient with
advanced stage microsatellite-unstable biliary tract cancer. Cold
Spring Harb Mol Case Stud. 3:a0019742017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Xiong Y, Li J, Zheng X, Zhou Q,
Turner A, Wu C, Lu B and Jiang J: PD-L1 expression promotes
epithelial to mesenchymal transition in human esophageal cancer.
Cell Physiol Biochem. 42:2267–2280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Howitt BE, Strickland KC, Sholl LM, Rodig
S, Ritterhouse LL, Chowdhury D, D'Andrea AD, Matulonis UA and
Konstantinopoulos PA: Clear cell ovarian cancers with
microsatellite instability: A unique subset of ovarian cancers with
increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression.
Oncoimmunology. 6:e12773082017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benatti P, Gafà R, Barana D, Marino M,
Scarselli A, Pedroni M, Maestri I, Guerzoni L, Roncucci L,
Menigatti M, et al: Microsatellite instability and colorectal
cancer prognosis. Clin Cancer Res. 11:8332–8340. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Richman S: Deficient mismatch repair: Read
all about it (Review). Int J Oncol. 47:1189–1202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhattacharya P and Patel TN:
Microsatellite instability and promoter hypermethylation of DNA
repair genes in hematologic malignancies: A forthcoming direction
toward diagnostics. Hematology. 23:77–82. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chapusot C, Martin L, Puig PL, Ponnelle T,
Cheynel N, Bouvier AM, Rageot D, Roignot P, Rat P, Faivre J and
Piard F: What is the best way to assess microsatellite instability
status in colorectal cancer? Study on a population base of 462
colorectal cancers. Am J Surg Pathol. 28:1553–1559. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ponti G, Losi L, Di Gregorio C, Roncucci
L, Pedroni M, Scarselli A, Benatti P, Seidenari S, Pellacani G,
Lembo L, et al: Identification of Muir-Torre syndrome among
patients with sebaceous tumors and keratoacanthomas: Role of
clinical features, microsatellite instability, and
immunohistochemistry. Cancer. 103:1018–1025. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ponti G, Losi L, Pedroni M, Lucci-Cordisco
E, Di Gregorio C, Pellacani G and Seidenari S: Value of MLH1 and
MSH2 mutations in the appearance of Muir-Torre syndrome phenotype
in HNPCC patients presenting sebaceous gland tumors or
keratoacanthomas. J Invest Dermatol. 126:2302–2307. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia JJ, Kramer MJ, O'Donnell RJ and
Horvai AE: Mismatch repair protein expression and microsatellite
instability: A comparison of clear cell sarcoma of soft parts and
metastatic melanoma. Mod Pathol. 19:950–957. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ponti G and Longo C: Microsatellite
instability and mismatch repair protein expression in sebaceous
tumors, keratocanthoma, and basal cell carcinomas with sebaceous
differentiation in Muir-Torre syndrome. J Am Acad Dermatol.
68:509–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nebot-Bral L, Coutzac C, Kannouche PL and
Chaput N: Why is immunotherapy effective (or not) in patients with
MSI/MMRD tumors? Bull Cancer. 106:105–113. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alvino E, Marra G, Pagani E, Falcinelli S,
Pepponi R, Perrera C, Haider R, Castiglia D, Ferranti G, Bonmassar
E, et al: High-frequency microsatellite instability is associated
with defective DNA mismatch repair in human melanoma. J Invest
Dermatol. 118:79–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ponti G, Losi L, Pellacani G, Wannesson L,
Cesinaro AM, Venesio T, Petti C and Seidenari S: Malignant melanoma
in patients with hereditary nonpolyposis colorectal cancer. Br J
Dermatol. 159:162–168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ponti G, Manfredini M, Greco S, Pellacani
G, Depenni R, Tomasi A, Maccaferri M and Cascinu S: BRAF, NRAS and
C-KIT advanced melanoma: Clinico-pathological features,
targeted-therapy strategies and survival. Anticancer Res.
37:7043–7048. 2017.PubMed/NCBI
|
|
19
|
Moscarella E, Pellegrini C, Pampena R,
Argenziano G, Manfredini M, Martorelli C, Ciarrocchi A, Dika E,
Peris K, Antonini A, et al: Dermoscopic similarity is an
independent predictor of BRAF mutational concordance in multiple
melanomas. Exp Dermatol. 28:829–835. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton C, Hess KR,
Sullivan DC, et al: Cancer Staging Manual8th. Springer; New York,
NY: 2017
|
|
21
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim ST, Klempner SJ, Park SH, Park JO,
Park YS, Lim HY, Kang WK, Kim KM and Lee J: Correlating programmed
death ligand 1 (PD-L1) expression, mismatch repair deficiency, and
outcomes across tumor types: Implications for immunotherapy.
Oncotarget. 8:77415–77423. 2017.PubMed/NCBI
|
|
23
|
Lage H, Christmann M, Kern MA, Dietel M,
Pick M, Kaina B and Schadendorf D: Expression of DNA repair
proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA
methyltransferase and N-methylpurine-DNA glycosylase in melanoma
cells with acquired drug resistance. Int J Cancer. 80:744–750.
1999. View Article : Google Scholar : PubMed/NCBI
|
